Discontinuation report ACT DILTIAZEM CD

Last updated on 2021-07-22 History
Report ID 142918
Drug Identification Number 02370654
Brand name ACT DILTIAZEM CD
Common or Proper name DILTIAZEM CD 300MG CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 300MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-03-10
Remaining supply date 2021-03-10
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-07-22 French Compare
v1 2021-07-22 English Compare

Showing 1 to 2 of 2